The “Leadership to Cure” Multiple Myeloma

Multiple Myeloma is the cancer of the blood. Dina Feivelson was diagnosed with Multiple Myeloma stage 3 in 2002 at the age of 32. When she was first diagnosed, no one thought she would see 40. Well, she proved statistics wrong with the help of her doctor and a miracle happened, as 8 years later Dina turned 40, and gave birth to twin girls. It’s a different life than anyone expected she’d be able to have, and now Dina proudly shares her story with other mothers, as she is a true inspiration.

Dina was treated at six different hospitals by 8 different doctors in 3 different states before she went to Mt. Sinai Hospital and met Dr. Jagganath. She first started on old fashioned traditional chemotherapy, got on a clinical trial, and then went through a stem cell transplantation with her own stem cells.  After the stem cell transplant, because
of the high risk it posed, and her very young age, “Dr. Jag” gave her a voluntary matched unrelated donor transplantation, where they thought the cancer was put to rest.  Since then, she has been in a near‐complete
remission, although over the last couple of months, her numbers have started to creep up again.  Dina continues to see Dr. Jag every month and is on two medications for Multiple Myeloma.

Dr. Sundar Jagannath, is a professor of medicine at Mount Sinai School of Medicine and the director of the Multiple Myeloma program. He is leading the way to build projects at Mount Sinai that bridge basic science and clinical practices for the benefit of advancing care in blood cancer patients everywhere.  The good news is that the current standard of care for Multiple Myeloma has dramatically improved over the past 10 years, especially with the approval of new drugs.

To learn more about Dina an the Multiple Myeloma program, check out LeadershipToCure.com.

If you enjoyed this post, please consider leaving a comment or subscribing to the RSS feed to have future articles delivered to your feed reader.